Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;32(2):106-9.

Hypogonadism and erectile dysfunction in myotonic dystrophy type 1

Stojan Peric  1 , Tanja Nisic  2 , Milena Milicev  1 , Ivana Basta  1 , Ivan Marjanovic  1 , Marina Peric  1 , Dragana Lavrnic  1 , Vidosava Rakocevic Stojanovic  1
Affiliations

Hypogonadism and erectile dysfunction in myotonic dystrophy type 1

Stojan Peric et al. Acta Myol. 2013 Oct.

Abstract

Myotonic dystrophy type 1 (DM1) is the most common form of muscular dystrophy in adults. It affects many organs and systems besides muscle. Aim of this study was to assess frequency of erectile dysfunction (ED) and hypogonadism, the correlation between them and the impact of ED on quality of life (QoL) in patients with DM1. A series of 25 men (aged from 22 to 58 years) with a diagnosis of DM1 was analyzed. Muscular Impairment Rating Scale (MIRS) was used to assess severity of muscular involvement. Erectile function was assessed using the short form of the International Index of Erectile Function test (IIEF-5). Levels of follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone were assessed. All patients completed the Serbian version of the SF-36 questionnaire as a measure of health-related QoL. ED was present in 18 (72%) of patients. Seven (28%) patients were euogonadic, 16 (64%) had compensated hypogonadism and 2 (8%) had primary hypogonadism. ED was somewhat more common in patients with hypogonadism (78% vs. 57%). Mental composite score of SF-36 was lower in patients with ED (p<0.05). Our results showed that 72% of men with DM1 had ED and hypogonadism. Studies with larger number of subjects are needed to resolve cascade of events that lays behind ED in DM1. Development of therapeutic strategies may have positive impact on QoL. Substitutive therapy with androgens may be benefitial.

Keywords: erectile dysfunction; hypogonadis; myotonic dystrophy type 1.

PubMed Disclaimer

References

    1. Kaufmann P. Progressive muscular dystrophies. In: Rowland L, editor. Merritt's Neurology. 11th ed. Philadelphia: LWW; 2005.
    1. Die-Smulders CE, Howeler CJ, Thijs C, et al. Age and causes of death in adult-onset myotonic dystrophy. Brain. 1998;121:1557–1563. - PubMed
    1. Mathieu J, Allard P, Porvin P, et al. A 10 year study of mortality in a cohort of patients with myotonic dystrophy. Neurology. 1999;52:1658–1662. - PubMed
    1. Mladenovic J, Pekmezovic T, Todorovic S, et al. Survival and mortality of myotonic dytrophy type 1 (Steinert's disease) in the population of Belgrade. Eur J Neurol. 2006;13:451–454. - PubMed
    1. Inoue K, Ogata H, Matsui M, et al. Assessment of autonomic function in myotonic dytrophy by spectral analysis of heart-rate variability. J Auton Nerv Syst. 1995;55:131–134. - PubMed

Publication types

MeSH terms

LinkOut - more resources